Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever (DISTALS)

The objective of the DISTALS Study is to evaluate the safety and effectiveness of the Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by removing thrombus in patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO), as compared to medical management.

For more information please visit https://clinicaltrials.gov/study/NCT05152524

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at 318-212-8130 .